IDUN Technologies is a Swiss neurotech startup headquartered in Glattpark (Opfikon) that develops in-ear EEG earbud technologies and brain analytics software.
Subscribe to see IDUN Technologies’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IDUN Technologies is a neurotechnology company headquartered in Switzerland. It has raised at least $2.2M across the 3 funding rounds on record, 1 of them with a disclosed amount. Its most recent funding round closed in September 2024. Xcout tracks 8 named people at IDUN Technologies, including Simon Bachmann (CEO).
2 more named people on record for IDUN Technologies, with roles, board committees and tenure — see the full roster →
At least $2.2M raised across the 3 rounds on record (1 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | Undisclosed | — | |
| Seed | $2.2M | — | |
| Pre-seed | Undisclosed | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of IDUN Technologies's closest competitors — see the full list of competitors and alternatives →
Quasar human.tech develops advanced dry EEG sensors and multi-modal physiological monitoring systems that measure signals like EEG, ECG, and respiration without the need for gels or skin abrasion. The company serves clients in human performance, healthcare, and commercial sectors by providing high-fidelity data acquisition technology for applications such as cognitive state evaluation, neurological monitoring, and clinical diagnostics.
Neurable Inc. is a Boston-based neurotechnology company specializing in AI-powered tools for brain signal translation, including integrated neurotechnology gaming headsets.
g.tec medical engineering develops and manufactures advanced hardware and software solutions for brain-computer interfaces, biosignal acquisition, and neurorehabilitation.
INBRAIN Neuroelectronics develops graphene-based brain-computer interface (BCI) platforms and AI-driven neurotherapeutics designed to decode and modulate neural signals. The company serves patients with brain disorders and neurological conditions, such as Parkinson's disease, by providing real-time, personalized autonomous therapy.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.